A 30-year-old male patient was diagnosed with early-onset, seronegative rheumatoid arthritis and started on subcutaneous methotrexate (7.5 mg) once weekly, along with folic acid supplement (5 mg weekly). After 8 months of regular therapy, he began complaining of recurrent headaches, vomiting, and blurring of vision. CT scan and MRI revealed normal study. Fundoscopy revealed bilateral papilledema, and lumbar puncture showed increased CSF pressure. He was diagnosed as having pseudotumor cerebri, or IIH. Methotrexate was suspected to be causing the IIH and was thus discontinued. However, recurrent projectile vomiting and headache continued for about 15 days. About 1 month later, there was abrupt onset of frightening auditory and visual hallucinations along with irrelevant speech and disturbed sleep. Patient was referred to the psychiatry department on the 3rd day after onset of psychosis. He was conscious, oriented to place and person, but not to time, sitting with a vacant look on his face, and speaking irrelevantly at times. There were no perceptual abnormalities at time of presentation. The vomiting and headache symptoms had become less frequent, but had not resolved. Family history revealed schizophrenia in his father. Patient was treated with low-dose antipsychotic (olanzapine 5 mg/day in two divided doses) and sedatives. Acetazolamide was given at a dosage of 250 mg/day for 14 days. After 2 weeks, he showed complete resolution of psychotic symptoms as well as symptoms due to increased intracranial pressure.